---
title: "MiniMed 股價因第四季度銷售增長及與雅培合作伙伴關係的擴展而上漲"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/288591098.md"
description: "MiniMed 的股票在盤前交易中上漲了 7%，達到 13.14 美元，此前公司報告第四季度營收為 8.37 億美元，超出預期。增長主要得益於國際銷售增長 22%。此外，MiniMed 還擴大了與雅培的合作伙伴關係，以商業化其智能給藥系統的葡萄糖 - 酮傳感器"
datetime: "2026-06-03T14:01:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288591098.md)
  - [en](https://longbridge.com/en/news/288591098.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288591098.md)
---

# MiniMed 股價因第四季度銷售增長及與雅培合作伙伴關係的擴展而上漲

By Katherine Hamilton

MiniMed shares rose after the company posted higher-than-expected revenue and expanded its partnership with Abbott Laboratories.

The stock advanced 7% to $13.14 in pre-market trading Wednesday.

The provider of diabetes management technology posted $837 million in sales in the fiscal fourth quarter, ahead of the $827.9 million analysts polled by FactSet expected.

Revenue growth was driven by a 22% increase in international sales.

MiniMed also said it expanded its agreement with Abbott to commercialize glucose-ketone sensors designed to integrate exclusively with MiniMed's smart dosing systems.

The agreement builds on the companies' existing partnership for the Instinct sensor, made by Abbott. It will bring expanded choice to MiniMed users across automated insulin delivery and Smart MDI systems.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

June 03, 2026 09:49 ET (13:49 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

### 相關股票

- [MMED.US](https://longbridge.com/zh-HK/quote/MMED.US.md)
- [ABT.US](https://longbridge.com/zh-HK/quote/ABT.US.md)
- [FDS.US](https://longbridge.com/zh-HK/quote/FDS.US.md)

## 相關資訊與研究

- [投資者對雅培（ABT）將 Libre Duo 的發佈與其最新股息批准結合在一起的反應如何](https://longbridge.com/zh-HK/news/289701586.md)
- [阿爾伯塔投資管理公司增加了對雅培 $ABT 的持股](https://longbridge.com/zh-HK/news/290011814.md)
- [SONY 發表 LYTIA L910 首款 LOFIC 感光元件！大型 1/1.28 吋 50MP 像素、「這功能」讓 HDR 更靚](https://longbridge.com/zh-HK/news/290266030.md)
- [MiniMed 推出的最小應用程序控制胰島素泵現已在美國上市 | MMED 股票新聞](https://longbridge.com/zh-HK/news/290059379.md)
- [瑞士信息與通信科技公司 Ovomind 研發情緒識別智能手環](https://longbridge.com/zh-HK/news/290171685.md)